• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ACADIA Pharmaceuticals Inc

+ Add to Watchlist

ACAD:US

32.9800 USD 0.1350 0.41%

As of 20:10:00 ET on 12/19/2014.

Company Profile for ACADIA Pharmaceuticals Inc (ACAD)

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Contact Information

ACADIA Pharmaceuticals Inc

11085 Torreyana Road
Suite 100
San Diego, CA 92121
United States
Phone: 1-858-558-2871
Fax: 1-858-558-2872

Key Executives for ACADIA Pharmaceuticals Inc (ACAD)

Uli HacksellPresident/CEOStephen R Davis "Steve"Exec VP/CFO/Chief Bus Ofcr
Terrence O MooreExec VP/Chief Commercial OfficerRoger M MillsExec VP:Dev/Chief Medical Ofcr
Glenn F BaityVP/Secy/General CounselLisa BarthelemyDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil